Chinese Journal of Pharmacovigilance ›› 2014, Vol. 11 ›› Issue (12): 746-748.

Previous Articles     Next Articles

Study on Incentive Policy for Pediatric Drug Research and Development

XU Shun-gui, LIU Chun-guang   

  1. Department of Pharmacy, Beijing Armed Police Corps Hospital, Beijing 100027,China
  • Received:2014-07-06 Revised:2016-02-03 Online:2014-12-08 Published:2016-03-02

Abstract: Objective The lack of pediatric drug is a common phenomenon at home and abroad. Improving the incentive policy for pediatric drug is an effective way to solve the shortage of drug for children. In this paper, through the analysis of research and development for the incentive policy of pediatric drug, put forward the incentive mechanism for suitable pediatric drug in China. Methods Search the official websites of WHO, FDA and MHRA, combining with the foreign advanced approaches for development of pediatric drug. And analyze the present situation and the problems in the pediatric drug development to offer proposals. Results and Conclusion We should pay attention to improve the legal framework of clinical trials in children, promote the development of suitable pediatric drug formulations, screen more pediatric drugs into the Essential Medicine List, and strengthen multi-sectoral joint collaboration.

Key words: pediatric drug, incentive policy

CLC Number: